Agency Information Collection Activities: Proposed Collection; Comment Request, 89104-89106 [2016-29584]
Download as PDF
<![CDATA[
89104
Federal Register / Vol. 81, No. 237 / Friday, December 9, 2016 / Notices
The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Understanding the Epidemiology of
Syphilis in the United States’’,
PS17–002.
MATTERS FOR DISCUSSION:
CONTACT PERSON FOR MORE INFORMATION:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30329, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–29456 Filed 12–8–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–10, CMS–
10487, CMS–10116, CMS–10219 and CMS–
10275]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
the accuracy of the estimated burden;
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:13 Dec 08, 2016
Jkt 241001
ways to enhance the quality, utility, and
clarity of the information to be
collected; and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
February 7, 2017.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–R–10 Advance Directives
(Medicare and Medicaid) and
Supporting Regulations
CMS–10487 Medicaid Emergency
Psychiatric Demonstration (MEPD)
Evaluation
CMS–10116 Conditions for Payment of
Power Mobility Devices, including
Power Wheelchairs and PowerOperated Vehicles
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
CMS–10219 Healthcare Effectiveness
Data and Information Set (HEDIS®)
Data Collection for Medicare
Advantage
CMS–10275 CAHPS Home Health Care
Survey
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Extension of a previously
approved collection; Title of
Information Collection: Advance
Directives (Medicare and Medicaid) and
Supporting Regulations; Use: The
advance directives requirement was
enacted because Congress wanted
individuals to know that they have a
right to make health care decisions and
to refuse treatment even when they are
unable to communicate. Steps have
been taken at both the Federal and State
level, to afford greater opportunity for
the individual to participate in
decisions made concerning the medical
treatment to be received by an adult
patient in the event that the patient is
unable to communicate to others, a
preference about medical treatment. The
individual may make his preference
known through the use of an advance
directive, which is a written instruction
prepared in advance, such as a living
will or durable power of attorney. This
information is documented in a
prominent part of the individual’s
medical record. Advance directives as
described in the Patient SelfDetermination Act have increased the
individual’s control over decisions
concerning medical treatment. Sections
4206 of the Omnibus Budget
Reconciliation Act of 1990 defined an
advance directive as a written
instruction recognized under State law
relating to the provision of health care
when an individual is incapacitated
E:\FR\FM\09DEN1.SGM
09DEN1
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 81, No. 237 / Friday, December 9, 2016 / Notices
(those persons unable to communicate
their wishes regarding medical
treatment).
All states have enacted legislation
defining a patient’s right to make
decisions regarding medical care,
including the right to accept or refuse
medical or surgical treatment and the
right to formulate advance directives.
Participating hospitals, skilled nursing
facilities, nursing facilities, home health
agencies, providers of home health care,
hospices, religious nonmedical health
care institutions, and prepaid or eligible
organizations (including Health Care
Prepayment Plans (HCPPs) and
Medicare Advantage Organizations
(MAOs) such as Coordinated Care Plans,
Demonstration Projects, Chronic Care
Demonstration Projects, Program of All
Inclusive Care for the Elderly, Private
Fee for Service, and Medical Savings
Accounts must provide written
information, at explicit time frames, to
all adult individuals about: (a) The right
to accept or refuse medical or surgical
treatments; (b) the right to formulate an
advance directive; (c) a description of
applicable State law (provided by the
State); and (d) the provider’s or
organization’s policies and procedures
for implementing an advance directive.
Form Number: CMS–R–10 (OMB control
number: 0938–0610); Frequency: Yearly;
Affected Public: Business or other forprofits; Number of Respondents: 39,479;
Total Annual Responses: 39,479; Total
Annual Hours: 2,836,441. (For policy
questions regarding this collection
contact Jeannine Cramer at 410–786–
5664.)
2. Type of Information Collection
Request: Extension of a previously
approved collection; Title of
Information Collection: Medicaid
Emergency Psychiatric Demonstration
(MEPD) Evaluation; Use: Since the
inception of Medicaid, inpatient care
provided to adults ages 21 to 64 in
institutions for mental disease (IMDs)
has been excluded from federal
matching funds. The Emergency
Medical Treatment and Active Labor
Act (EMTALA), however, requires IMDs
that participate in Medicare to provide
treatment for psychiatric emergency
medical conditions (EMCs), even for
Medicaid patients for whose services
cannot be reimbursed. Section 2707 of
the Affordable Care Act (ACA) directs
the Secretary of Health and Human
Services to conduct and evaluate a
demonstration project to determine the
impact of providing payment under
Medicaid for inpatient services
provided by private IMDs to individuals
with emergency psychiatric conditions
between the ages of 21 and 64. We will
use the data to evaluate the Medicaid
VerDate Sep<11>2014
18:13 Dec 08, 2016
Jkt 241001
Emergency Psychiatric Demonstration
(MEPD) in accordance with the ACA
mandates. This evaluation in turn will
be used by Congress to determine
whether to continue or expand the
demonstration. If the decision is made
to expand the demonstration, the data
collected will help to inform both CMS
and its stakeholders about possible
effects of contextual factors and
important procedural issues to consider
in the expansion, as well as the
likelihood of various outcomes. Form
Number: CMS–10487 (OMB control
number: 0938–NEW); Frequency:
Annually; Affected Public: Individuals
and households; State, Local and Tribal
governments; Business and other forprofits and Not-for-profits; Number of
Respondents: 93; Total Annual
Responses: 1,944; Total Annual Hours:
2,046. (For policy questions regarding
this collection contact Vetisha McClair
at 410–786–4923.)
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Conditions for
Payment of Power Mobility Devices,
including Power Wheelchairs and
Power-Operated Vehicles; Use: We are
renewing our request for approval for
the collection requirements associated
with the final rule, CMS–3017–F (71 FR
17021), which published on April 5,
2006, and required a face-to-face
examination of the beneficiary by the
physician or treating practitioner, a
written prescription, and receipt of
pertinent parts of the medical record by
the supplier within 45 days after the
face-to-face examination that the
durable medical equipment (DME)
suppliers maintain in their records and
make available to CMS and its agents
upon request. Form Number: CMS–
10116 (OMB control number: 0938–
0971); Frequency: Yearly; Affected
Public: Private Sector—Business or
other for-profits; Number of
Respondents: 46,000; Number of
Responses: 72,500; Total Annual Hours:
14,434. (For policy questions regarding
this collection contact Stuart Caplan at
410–786–8564.)
4. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Healthcare
Effectiveness Data and Information Set
(HEDIS®) Data Collection for Medicare
Advantage; Use: We use the collected
data to: Monitor Medicare Advantage
organization performance, inform audit
strategies, and inform beneficiary choice
through their display in our consumeroriented public compare tools and Web
sites. Medicare Advantage organizations
use the data for quality assessment and
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
89105
as part of their quality improvement
programs and activities. Quality
Improvement Organizations and our
contractors use HEDIS® data in
conjunction with their statutory
authority to improve quality of care.
Consumers use the information to help
make informed health care choices. In
addition, the data is made available to
researchers and others as public use
files at www.cms.hhs.gov. Form
Number: CMS–10219 (OMB control
number: 0938–1028); Frequency: Yearly;
Affected Public: Private sector—
Business or other for-profit and Not-forprofit institutions; Number of
Respondents: 576; Total Annual
Responses: 576; Total Annual Hours:
184,320. (For policy questions regarding
this collection contact Lori Teichman at
410–786–6684.)
5. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: CAHPS Home
Health Care Survey; Use: The national
implementation of the Home Health
Care Consumer Assessment of
Healthcare Providers and Systems
(CAHPS®) Survey is designed to collect
ongoing data from samples of home
health care patients who receive skilled
services from Medicare-certified home
health agencies. The data collected from
the national implementation of the
Home Health Care CAHPS Survey will
be used for the following purposes: (1)
To produce comparable data on the
patients’ perspectives of the care they
receive from home health agencies, (2)
to create incentives for agencies to
improve the quality of care they provide
through public reporting of survey
results, and (3) to enhance public
accountability in health care by
increasing the transparency of the
quality of care provided in return for the
public investment. Sampling and data
collection will be conducted on a
monthly basis. Survey results will be
analyzed and reported on a quarterly
basis, with publicly reported results
based on one year’s worth of data.
As part of this information collection
request for the national implementation
of Home Health Care CAHPS, CMS is
also requesting approval to conduct a
randomized mode experiment with a
sample of home health agencies. The
mode experiment compared the
responses to the survey across the three
proposed modes to determine whether
adjustments are needed to ensure that
the data collection mode does not
influence the survey results. In addition,
data from the mode experiment will be
used to determine which, if any, patient
characteristics may affect the patients’
rating of the care they receive and, if so,
E:\FR\FM\09DEN1.SGM
09DEN1
89106
Federal Register / Vol. 81, No. 237 / Friday, December 9, 2016 / Notices
develop an adjustment model of those
data based on those factors. CMS
worked with RTI, the federal contractor
to recruit approximately 100 home
health agencies to participate in the
mode experiment. The mode
experiment included approximately
23,000 home health care patients.
Form Number: CMS–10275 (OMB
control number: 0938–1066); Frequency:
Quarterly; Affected Public: Individuals
and households and the Private sector
(Business or other for-profit and Not-forprofit institutions); Number of
Respondents: 2,715,890; Total Annual
Responses: 2,715,890; Total Annual
Hours: 699,440. (For policy questions
regarding this collection contact Lori
Teichman at 410–786–6684.)
Dated: December 6, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2016–29584 Filed 12–8–16; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–2431–N]
Zika Health Care Services Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
November 9, 2016 publication of a
funding opportunity providing up to
$66.1 million available to support
prevention activities and treatment
services for health conditions related to
the Zika virus. The funding opportunity
solicited single source emergency
applications for a cooperative agreement
aimed at supporting prevention
activities and treatment services for
women (including pregnant women),
children, and men adversely or
potentially impacted by the Zika virus.
Entities eligible to apply for this funding
opportunity are states, territories, tribes
or tribal organizations, with active or
local transmission of the Zika virus, as
confirmed by the Centers for Disease
Control and Prevention (CDC). As of
October 12, 2016, the CDC designated
American Samoa, Puerto Rico, the U.S.
Virgin Islands, and Florida as areas with
laboratory-confirmed active or local
Zika virus transmission. As such, this
emergency funding opportunity is
currently available to the territorial and
state health departments in these areas.
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:13 Dec 08, 2016
Jkt 241001
The project period of
performance for the Cooperative
Agreement will be 36 months from the
date of award.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Garbarczyk, 410–786–0426.
SUPPLEMENTARY INFORMATION:
DATES:
I. Background
The Zika Response and Preparedness
Act (Pub. L. 114–223) provides
$387,000,000 in funding to prevent,
prepare for, and respond to the Zika
virus. Of the funds appropriated by
Public Law 114–223, Congress
designated $75 million to support states,
territories, tribes, or tribal organizations
with active or local transmission cases
of the Zika virus, as confirmed by the
Centers for Disease Control and
Prevention (CDC), to reimburse the costs
of health care for health conditions
related to the Zika virus not covered by
private insurance. No less than $60
million of this funding is for territories
with the highest rates of Zika
transmission.
II. Provisions of the Notice
In accordance with the Zika Response
and Preparedness Act (Pub. L. 114–223),
entities eligible to apply for this funding
opportunity include states, territories,
tribes or tribal organizations with active
or local transmission of the Zika virus,
as confirmed by the Centers for Disease
Control and Prevention (CDC). As of
October 12, 2016, the CDC reports that
American Samoa, Puerto Rico, the U.S.
Virgin Islands, and Florida are the only
areas with laboratory-confirmed active
or local transmission of the Zika virus,
and therefore, these are the only
territories and state eligible to receive
funding as authorized under the
legislation. Funding available under the
‘‘Zika Health Care Services Program’’
may be used to address the following
four critical components of a
comprehensive response to Zika.
Applicant needs may vary and some
applicants may not have unmet needs
across each of the four areas. If
approved by CMS, recipients may use
grant funds for additional health care
services for health conditions related to
the Zika virus that are not listed in the
following section.
1. Increase Access to Contraceptive
Services for Women and Men
Contraceptive services for women and
men can reduce the risk of unintended
pregnancy, as well as sexual
transmission of Zika. Preventing
unintended pregnancy in areas affected
by the Zika virus outbreak among
people who may have been exposed is
a primary strategy to reduce the number
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
of pregnancies affected by Zika virus. To
increase access to all FDA-approved
contraceptive methods, a territory or
state must use grant funds to provide
client-centered contraceptive counseling
to educate women (including women
who are pregnant and post-partum) and
men on effective contraception
methods, increase contraceptive
supplies in provider offices, increase
family planning delivery sites, train
providers on the full range of
contraceptive methods and their use,
including insertion and removal of longacting reversible contraception (LARC),
and to remove a patient’s financial
barriers to use of effective contraception
through methods such as cost sharing
assistance for contraceptive services.
2. Reduce Barriers to Diagnostic Testing,
Screening, and Counseling for Pregnant
Women and Newborns
Uninsured or underinsured pregnant
women may not seek testing and
medical follow-up if Zika testing does
not begin at the initial point of prenatal
care or if it presents financial hardship.
Testing should be performed as a part of
routine prenatal care. However,
additional unscheduled prenatal visits
may be necessary to complete the
testing protocol (for example, reflex
testing) and to provide pre- and post-test
counseling on the interpretation of
results. Funds designated for diagnostic
testing, screening, and counseling will
be used to ensure access to diagnostic
services to test for Zika infection
wherever a pregnant woman initially
presents for care. This will increase the
identification of pregnant women
infected with Zika, who require
increased monitoring and prenatal care
services, and will lead to early diagnosis
of infants with special medical needs.
3. Increase Access to Appropriate
Specialized Healthcare Services for
Pregnant Women, Children Born to
Mothers With Maternal Zika Virus
Infection, and Their Families
Complex clinical and psychosocial
needs associated with maternal Zika
virus infection require access to
comprehensive and appropriate
specialized healthcare, and a
coordinated suite of services that serves
mother, child, and their families.
Increased access to prenatal care is
critical to plan for post-natal care,
particularly access to ultrasounds which
can detect abnormalities in fetal
development. In addition, high-risk
pregnancies and pregnancy loss, can be
stressful for both the pregnant woman
and her family and require psychosocial
support. Moreover, the infants
themselves require enhanced follow-up,
E:\FR\FM\09DEN1.SGM
09DEN1
]]>Agencies
[Federal Register Volume 81, Number 237 (Friday, December 9, 2016)]
[Notices]
[Pages 89104-89106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29584]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-R-10, CMS-10487, CMS-10116, CMS-10219 and
CMS-10275]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including any of the following subjects: The
necessity and utility of the proposed information collection for the
proper performance of the agency's functions; the accuracy of the
estimated burden; ways to enhance the quality, utility, and clarity of
the information to be collected; and the use of automated collection
techniques or other forms of information technology to minimize the
information collection burden.
DATES: Comments must be received by February 7, 2017.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' Web site address at https://www.cms.hhs.gov/PaperworkReductionActof1995.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: Reports Clearance Office at (410) 786-
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-R-10 Advance Directives (Medicare and Medicaid) and Supporting
Regulations
CMS-10487 Medicaid Emergency Psychiatric Demonstration (MEPD)
Evaluation
CMS-10116 Conditions for Payment of Power Mobility Devices, including
Power Wheelchairs and Power-Operated Vehicles
CMS-10219 Healthcare Effectiveness Data and Information Set
(HEDIS[supreg]) Data Collection for Medicare Advantage
CMS-10275 CAHPS Home Health Care Survey
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Extension of a
previously approved collection; Title of Information Collection:
Advance Directives (Medicare and Medicaid) and Supporting Regulations;
Use: The advance directives requirement was enacted because Congress
wanted individuals to know that they have a right to make health care
decisions and to refuse treatment even when they are unable to
communicate. Steps have been taken at both the Federal and State level,
to afford greater opportunity for the individual to participate in
decisions made concerning the medical treatment to be received by an
adult patient in the event that the patient is unable to communicate to
others, a preference about medical treatment. The individual may make
his preference known through the use of an advance directive, which is
a written instruction prepared in advance, such as a living will or
durable power of attorney. This information is documented in a
prominent part of the individual's medical record. Advance directives
as described in the Patient Self-Determination Act have increased the
individual's control over decisions concerning medical treatment.
Sections 4206 of the Omnibus Budget Reconciliation Act of 1990 defined
an advance directive as a written instruction recognized under State
law relating to the provision of health care when an individual is
incapacitated
[[Page 89105]]
(those persons unable to communicate their wishes regarding medical
treatment).
All states have enacted legislation defining a patient's right to
make decisions regarding medical care, including the right to accept or
refuse medical or surgical treatment and the right to formulate advance
directives. Participating hospitals, skilled nursing facilities,
nursing facilities, home health agencies, providers of home health
care, hospices, religious nonmedical health care institutions, and
prepaid or eligible organizations (including Health Care Prepayment
Plans (HCPPs) and Medicare Advantage Organizations (MAOs) such as
Coordinated Care Plans, Demonstration Projects, Chronic Care
Demonstration Projects, Program of All Inclusive Care for the Elderly,
Private Fee for Service, and Medical Savings Accounts must provide
written information, at explicit time frames, to all adult individuals
about: (a) The right to accept or refuse medical or surgical
treatments; (b) the right to formulate an advance directive; (c) a
description of applicable State law (provided by the State); and (d)
the provider's or organization's policies and procedures for
implementing an advance directive. Form Number: CMS-R-10 (OMB control
number: 0938-0610); Frequency: Yearly; Affected Public: Business or
other for-profits; Number of Respondents: 39,479; Total Annual
Responses: 39,479; Total Annual Hours: 2,836,441. (For policy questions
regarding this collection contact Jeannine Cramer at 410-786-5664.)
2. Type of Information Collection Request: Extension of a
previously approved collection; Title of Information Collection:
Medicaid Emergency Psychiatric Demonstration (MEPD) Evaluation; Use:
Since the inception of Medicaid, inpatient care provided to adults ages
21 to 64 in institutions for mental disease (IMDs) has been excluded
from federal matching funds. The Emergency Medical Treatment and Active
Labor Act (EMTALA), however, requires IMDs that participate in Medicare
to provide treatment for psychiatric emergency medical conditions
(EMCs), even for Medicaid patients for whose services cannot be
reimbursed. Section 2707 of the Affordable Care Act (ACA) directs the
Secretary of Health and Human Services to conduct and evaluate a
demonstration project to determine the impact of providing payment
under Medicaid for inpatient services provided by private IMDs to
individuals with emergency psychiatric conditions between the ages of
21 and 64. We will use the data to evaluate the Medicaid Emergency
Psychiatric Demonstration (MEPD) in accordance with the ACA mandates.
This evaluation in turn will be used by Congress to determine whether
to continue or expand the demonstration. If the decision is made to
expand the demonstration, the data collected will help to inform both
CMS and its stakeholders about possible effects of contextual factors
and important procedural issues to consider in the expansion, as well
as the likelihood of various outcomes. Form Number: CMS-10487 (OMB
control number: 0938-NEW); Frequency: Annually; Affected Public:
Individuals and households; State, Local and Tribal governments;
Business and other for-profits and Not-for-profits; Number of
Respondents: 93; Total Annual Responses: 1,944; Total Annual Hours:
2,046. (For policy questions regarding this collection contact Vetisha
McClair at 410-786-4923.)
3. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Conditions for
Payment of Power Mobility Devices, including Power Wheelchairs and
Power-Operated Vehicles; Use: We are renewing our request for approval
for the collection requirements associated with the final rule, CMS-
3017-F (71 FR 17021), which published on April 5, 2006, and required a
face-to-face examination of the beneficiary by the physician or
treating practitioner, a written prescription, and receipt of pertinent
parts of the medical record by the supplier within 45 days after the
face-to-face examination that the durable medical equipment (DME)
suppliers maintain in their records and make available to CMS and its
agents upon request. Form Number: CMS-10116 (OMB control number: 0938-
0971); Frequency: Yearly; Affected Public: Private Sector--Business or
other for-profits; Number of Respondents: 46,000; Number of Responses:
72,500; Total Annual Hours: 14,434. (For policy questions regarding
this collection contact Stuart Caplan at 410-786-8564.)
4. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Healthcare
Effectiveness Data and Information Set (HEDIS[supreg]) Data Collection
for Medicare Advantage; Use: We use the collected data to: Monitor
Medicare Advantage organization performance, inform audit strategies,
and inform beneficiary choice through their display in our consumer-
oriented public compare tools and Web sites. Medicare Advantage
organizations use the data for quality assessment and as part of their
quality improvement programs and activities. Quality Improvement
Organizations and our contractors use HEDIS[supreg] data in conjunction
with their statutory authority to improve quality of care. Consumers
use the information to help make informed health care choices. In
addition, the data is made available to researchers and others as
public use files at www.cms.hhs.gov. Form Number: CMS-10219 (OMB
control number: 0938-1028); Frequency: Yearly; Affected Public: Private
sector--Business or other for-profit and Not-for-profit institutions;
Number of Respondents: 576; Total Annual Responses: 576; Total Annual
Hours: 184,320. (For policy questions regarding this collection contact
Lori Teichman at 410-786-6684.)
5. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: CAHPS Home Health
Care Survey; Use: The national implementation of the Home Health Care
Consumer Assessment of Healthcare Providers and Systems (CAHPS[supreg])
Survey is designed to collect ongoing data from samples of home health
care patients who receive skilled services from Medicare-certified home
health agencies. The data collected from the national implementation of
the Home Health Care CAHPS Survey will be used for the following
purposes: (1) To produce comparable data on the patients' perspectives
of the care they receive from home health agencies, (2) to create
incentives for agencies to improve the quality of care they provide
through public reporting of survey results, and (3) to enhance public
accountability in health care by increasing the transparency of the
quality of care provided in return for the public investment. Sampling
and data collection will be conducted on a monthly basis. Survey
results will be analyzed and reported on a quarterly basis, with
publicly reported results based on one year's worth of data.
As part of this information collection request for the national
implementation of Home Health Care CAHPS, CMS is also requesting
approval to conduct a randomized mode experiment with a sample of home
health agencies. The mode experiment compared the responses to the
survey across the three proposed modes to determine whether adjustments
are needed to ensure that the data collection mode does not influence
the survey results. In addition, data from the mode experiment will be
used to determine which, if any, patient characteristics may affect the
patients' rating of the care they receive and, if so,
[[Page 89106]]
develop an adjustment model of those data based on those factors. CMS
worked with RTI, the federal contractor to recruit approximately 100
home health agencies to participate in the mode experiment. The mode
experiment included approximately 23,000 home health care patients.
Form Number: CMS-10275 (OMB control number: 0938-1066); Frequency:
Quarterly; Affected Public: Individuals and households and the Private
sector (Business or other for-profit and Not-for-profit institutions);
Number of Respondents: 2,715,890; Total Annual Responses: 2,715,890;
Total Annual Hours: 699,440. (For policy questions regarding this
collection contact Lori Teichman at 410-786-6684.)
Dated: December 6, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2016-29584 Filed 12-8-16; 8:45 am]
BILLING CODE 4120-01-P
